Martin, Silas C.; Gagnon, Dennis D.; Zhang, Lucy; … - In: PharmacoEconomics 21 (2003) 16, pp. 1153-1169
Background: In a multinational trial of anaemic patients with cancer receiving nonplatinum-containing chemotherapy, epoetin-alfa effectively increased haemoglobin levels, reduced red blood cell transfusion requirements, and improved QOL. Although the study was not designed or powered to evaluate...